GVR Report cover Endoscopy Devices Market Size, Share & Trends Report

Endoscopy Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-3-68038-468-0
  • Number of Pages: 118
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2020
  • Industry: Healthcare

Report Overview

The endoscopy devices market size was valued at USD 42.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2022 to 2030. The less invasive properties and affordable post and pre-procedure cost of endoscopy devices are the major factors anticipated to boost the market growth over the forecast period. Furthermore, a shift in trend to use disposable endoscopic components to minimize the procedure cost as well as the chance of cross-contamination is also expected to accelerate market growth over the years.

U.S. endoscopy devices market size, by product, 2020 - 2030 (USD Billion)

In addition, the growing chronic disease burden and increasing geriatric population all over the globe are also anticipated to fuel the adoption of endoscopic devices during the coming years. Moreover, growing medical conditions due to the increasing geriatric population often require endoscopic intervention such as liver abscess, gall stones, endometriosis, and intestinal perforation, which in turn are anticipated to drive the market for endoscopy devices over the forecast years. For instance, as per the Administration on Aging (AoA) of the U.S. Department of Health and Human Services report, about 16% of the population were aged above 65 years during 2019. This number is expected to increase to 21.6% by 2040.

In addition, increasing preference by medical professionals to use technologically advanced endoscopy devices equipped with a high-definition camera and light sources to help physicians analyze internal organs of interest also drives the market. The shift of preference towards minimally invasive surgical procedures than traditional surgeries to reduce hospital stay and minimize post-procedure complications are the major factors anticipated to fuel the demand for endoscopy devices. Hence, factors such as higher patient satisfaction, increased economic viability, and lesser hospital stay are expected to increase the demand for minimally invasive endoscopic interventions in the coming years, thereby accelerating market growth.

Furthermore, the growing burden of cancer all over the world also fuels the adoption of endoscopy devices for the early diagnosis and treatment of the disease. For instance, according to GLOBOCAN 2020 estimates 19.3 million new cancer cases worldwide and almost 10 million death occurred in 2020 due to cancer. In addition, the increasing preference for biopsies for diagnosis and detection of cancer in recent years is also likely to increase the adoption of endoscopic devices, which in turn is anticipated to drive the market for endoscopy devices over the years.

Technological advancement to develop innovative endoscopic devices is also anticipated to accelerate market growth during forecast periods. The key manufacturers are continuously looking forward to innovating advanced endoscopic solutions for better treatment and diagnosis of several chronic disorders. For instance, in August 2021, Fujifilm Holdings Corporation announced the commercial launch of the ELUXEO 7000X endoscopic Imaging System. This advanced imaging system enables real-time visualization of hemoglobin oxygen saturation (StO2) levels in tissue during laparoscopic and/or endoluminal imaging procedures.

COVID19 Endoscopy devices market estimates impact: 3.4% decrease in revenue growth from 2019 to 2020

Pandemic Impact

Post COVID Outlook

The Global endoscopy devices market estimates decreased by 3.4% from 2019 to 2020

The market is estimated to witness a y-o-y growth of approximately 6.9% to 7.4% in the next 5 years

The decrease in the market growth is due to the decrease in a number of endoscopic procedures during 2020 due to the COVID-19 pandemic as compared to 2019. In addition, the canceled or postponed semi-urgent and elective endoscopic procedures by the healthcare centers due to the fear of COVID-19 infection also restrained market growth.

The growing number of functional gastrointestinal disorders and cancer cases and the increase in the preference for cost-effective minimally invasive endoscopic procedures for the early diagnosis and detection of chronic diseases are anticipated to propel the adoption of endoscopic devices over the forecast years.

Furthermore, supply chain disruption, the shortage of healthcare professionals due to the COVID-19 infection, and changing regulations to curtail the infection in major geographic regions resulted in a significant impact on the global market growth in 2020.

High preference for disposable endoscopic equipment to minimize the chances of cross-contamination coupled with the technological advancement to develop cost-effective products helps in shortening the procedure time and these are the factors expected to accelerate market growth over the forecast years.

 

In addition, the endoscopy devices market has been significantly impacted by the COVID-19 pandemic. The reduction and postponement of elective surgeries due to the fear of COVID-19 infection have negatively impacted the growth of the market for endoscopy devices. In addition, supply chain disruptions, changing regulations for surgical procedures, are some of the factors that also hampered market growth in 2020. For instance, according to an international study published in the Arab Journal of Gastroenterology, Elsevier in 2020, the endoscopic procedure volume was reduced by over 50% of the 85% of the responded countries all over the world during the COVID-19 pandemic.

Product Insights 

The endoscopy visualization systems segment accounted for the largest revenue share of 36.5% in 2021 owing to their wide adoption during endoscopy procedures and increasing application for the visualization and diagnosis of complex disease conditions such as cancer, GI disorders, urinary disorders, and lung disorders. In addition, the availability of next-generation endoscopy visualization systems which enables surgeons to visualize the internal organ of choice with the minimally invasive procedure is further boosting its adoption and signifying higher share to the segment. 

In addition, the endoscopes segment accounted for a CAGR of 9.4% in the market for endoscopy devices during the forecast period. This high growth rate is attributed due to the increasing number of endoscopic procedures coupled with the high adoption of endoscopes to perform surgeries and biopsies for better diagnosis and treatment. The flexible endoscopes segment dominated the endoscopes segment and accounted for a high revenue share in 2021, owing to its high preference of use by medical professionals and its advantages such as safety, increased efficiency, and enhanced ergonomics as compared to rigid endoscopes.

Application Insights

The Gastrointestinal (GI) endoscopy segment dominated the market for endoscopy devices and accounted for a revenue share of 54.7% in 2021. This high share of the segment is attributable to the increasing geriatric population and the growing burden of functional gastrointestinal diseases. In addition, rising preference for endoscopy procedure as first-line treatment for early detection and diagnosis of functional gastrointestinal disorders and the availability of technologically advanced endoscopes are some of the major factors driving the growth of the segment. 

Furthermore, the urology endoscopy segment is anticipated to witness the fastest growth rate over the forecast years owing to the increasing prevalence of chronic urological diseases such as cancer and tumor and the growing number of cystoscopy procedures. For instance, as per the report published by Cancer Research U.K., each year there are about 10,300 new cases of bladder cancer in the U.K. and it is the 11th most common cancer in the U.K. Since cystoscopy is the main diagnostic procedure for bladder cancer, it is anticipated to fuel the segment growth over the forecast years. 

End-use Insights

The hospital's segment dominated the market for endoscopy devices and accounted for the highest revenue share of 48.1% in 2021. Hospitals are generally considered as primary health systems and the increase in preference of hospitals for the diagnosis and treatment of chronic disorders by the patient population is also fueling the segment growth. In addition, a large number of surgeries performed in hospitals including endoscopy procedures also increase the endoscopy devices adoption thereby supporting segment growth.

Global endoscopy devices market share, by end use, 2021 (%) 

Furthermore, the ambulatory surgery centers/clinics segment is anticipated to witness the highest CAGR during forecast years. Growing preference for minimally invasive procedures to lower overall cost and reduce the number of days of hospital stays are some of the major factors expected to drive the growth of the segment. In addition, faster recovery time, and minimal discomfort due to the use of less invasive keyhole endoscopic procedures also accelerates the adoption of endoscopy devices in ambulatory surgery centers/clinics, which in turn is anticipated to propel segment growth over the forecast period. 

Regional Insights 

In 2021, North America accounted for the highest revenue share of 42.3% in the market for endoscopy devices. This is attributed due to the growing prevalence of several chronic diseases such as cancer, diabetes, cardiovascular diseases along functional gastrointestinal disorders. In addition, the increasing geriatric population, those who are prone to several chronic disorders also propelling the adoption of endoscopic procedures in this region. Moreover, growing awareness for early disease diagnosis using minimally invasive procedures and improved healthcare infrastructure are further boosting the market growth in this region. 

Furthermore, in Asia Pacific, the market for endoscopy devices is expected to witness the fastest growth rate over the forecast years owing to the large population and an increasing number of functional gastrointestinal disorder patients. In addition, growing demand for the minimally invasive endoscopic procedure and improving health care infrastructure are also anticipated to accelerate the region's growth in the market. Moreover, increasing government initiatives to modernize healthcare facilities and constantly develop a start-up landscape are among the major factors further promoting the growth of the market in the region. 

Key Companies & Market Share Insights 

The high demand for technologically advanced endoscopic products for diagnosis and treatment of several chronic disorders makes the completion intense among the existing players. In addition, growing preference for the minimally invasive procedure with low cost, safety and reduced chance of contamination devices further increase the competition.  Moreover, the top market players also adopting business strategies such as new product launches, collaboration, mergers and acquisitions to increase their product portfolio and market share in the area of endoscopic devices. For instance, in September 2020, PENTAX Medical announced to launch new Ultrasound Video Gastroscopes J10 Series in the U.S. These advanced gastroscopes enable better image quality, increase diagnostic capabilities, and help in effective disease management of the patient. Some of the prominent players in the endoscopy devices market include:

  • Olympus Corporation

  • Ethicon Endo-surgery, LLC.

  • FUJIFILM Holdings Corporation

  • Stryker Corporation

  • Boston Scientific Corporation

  • Karl Storz GmbH & Co. KG

  • Smith & Nephew Inc.

  • Richard Wolf GmbH

  • Medtronic Plc (Covidien)

  • PENTAX Medical

  • Machida Endoscope Co., Ltd.

Endoscopy Devices Market Report Scope

Report Attribute

Details

Market size value in 2022

USD 45.6 billion

Revenue forecast in 2030

USD 81.0 billion

Growth Rate

CAGR of 7.4% from 2022 to 2030

Base year for estimation

2021

Historical data

2014 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; Spain; France; Italy; Russia; Switzerland; Denmark; China; Japan; India; Australia; New Zealand; Thailand; Indonesia; Malaysia; Vietnam; Philippines; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait; Israel; Qatar

Key companies profiled

Olympus Corporation; Ethicon Endo-surgery LLC.; FUJIFILM Holdings Corporation; Stryker Corporation; Boston Scientific Corporation; Karl Storz GmbH & Co. KG.; Smith & Nephew Inc.; Richard Wolf GmbH; Medtronic Plc (Covidien); PENTAX Medical; Machida Endoscope Co., Ltd.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Segments Covered in the Report 

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2030. For the purpose of this study, Grand View Research, Inc. has segmented the global endoscopy devices market report on the basis of product, application, end use, and region: 

  • Product Outlook (Revenue, USD Million, 2014 - 2030)

    • Endoscopes

      • Rigid Endoscopy Devices

        • Laparoscopes

        • Arthroscopes

        • Urology endoscopes

        • Cystoscopes

        • Gynecology endoscopes

        • Neuroendoscopes

        • Other rigid endoscopes

      • Flexible Endoscopy Devices

        • Upper gastrointestinal endoscopes

        • Colonoscopes

        • Bronchoscopes

        • Sigmoidoscopes

        • Laryngoscopes

        • Pharyngoscopes

        • Duodenoscopes

        • Nasopharyngoscopes

        • Rhinoscopes

        • Other flexible Endoscopy Devices

      • Capsule Endoscopy Devices

      • Disposable Endoscopy Devices

      • Robot Assisted Endoscopy Devices

    • Endoscopy Visualization Systems

      • Standard Definition (SD) Visualization Systems

        • 2D systems

        • 3D systems

      • High Definition (HD) Visualization Systems

        • 2D systems

        • 3D systems

      • Endoscopy Visualization Component

        • Camera Heads

        • Insufflators

        • Light Sources

        • High Definition Monitors

        • Suction Pumps

        • Video Processors

      • Operative Devices

        • Energy Systems

        • Access Devices

        • Suction & Irrigation Systems

        • Hand Instruments

        • Wound Retractors

        • Snares

  • Application Outlook (Revenue, USD Million, 2014 - 2030)

    • Gastrointestinal (GI) endoscopy

    • Laparoscopy

    • Obstetrics/gynecology endoscopy

    • Arthroscopy

    • Urology endoscopy (cystoscopy)

    • Bronchoscopy

    • Mediastinoscopy

    • Otoscopy

    • Laryngoscopy

    • Other applications

  • End-use Outlook (Revenue, USD Million, 2014 - 2030)

    • Hospitals

    • Ambulatory surgery centers

    • Other end uses

  • Regional Outlook (Revenue, USD Million, 2014 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • Italy

      • France

      • Spain

      • Russia

      • Switzerland

      • Denmark

    • Asia Pacific

      • Australia

      • China

      • Japan

      • India

      • New Zealand

      • Thailand

      • Indonesia

      • Malaysia

      • Vietnam

      • Philippines

    • Latin America

      • Mexico

      • Brazil

      • Argentina

    • Middle East Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

      • Israel

      • Qatar

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.